In a mouse model of nonalcoholic fatty liver disease (NAFLD), SIRT2 regulated deacetylation and deubiquitylation of the fibronectin type III structural domain Fndc5, a process dependent on NAD+. Here, FNDC5 is linked to metabolic dysfunction-associated steatotic liver disease.